Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights
Pharmacology Research & Perspectives · 2025
DOI: 10.1002/prp2.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Chih-Wei Tung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Huntington Disease, Neuroprotective Agents, Deoxyadenosines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Huntington's disease (HD) is a challenging neurodegenerative disorder linked to Huntingtin ( HTT ) gene mutation, lacking an effective cure despite numerous therapeutic attempts. Cordyceps sinensis , recognized for its health benefits, particularly its constituent cordycepin, exhibits neuroprotective effects in various neurodegenerative diseases. However, the neuroprotective potential of cordycepin in HD remains insufficiently explored. In this study, in vitro experiments using HD cell models demonstrate that cordycepin treatment enhances cell survival, slightly diminishes mutant HTT aggregates, and improves neuronal formation. In vivo investigations on R6/2 HD transgenic mice reveal a modest increase in body weight and a slight amelioration in pathological aggregates following cordycepin administration, although behavioral changes are not significant. While the underlying mechanisms remain unexplored, the findings suggest cordycepin's promise as a supplementary therapeutic for HD, providing neuroprotective effects and reducing mutant protein aggregates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Food Safety/Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Shang-Hsun Yang
Förderung
- National Science and Technology Council
Zitieren
APA
Tung, C. W., Chan, S. C., Cheng, P. H., Chen, Y. C., Wu, P. M., Lin, W. C., Chen, R. J., Huang, B. M., & Yang, S. H. (2025). Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70091
Vancouver
Tung CW, Chan SC, Cheng PH, Chen YC, Wu PM, Lin WC, et al. Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70091
BibTeX
@article{Tung2025,
author = {Tung, Chih-Wei and Chan, Siew Chin and Cheng, Pei-Hsun and Chen, Yi-Ching and Wu, Po-Ming and Lin, Wei-Chen and Chen, Rong-Jane and Huang, Bu-Miin and Yang, Shang-Hsun},
title = {Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights},
journal = {Pharmacology Research & Perspectives},
year = {2025},
doi = {10.1002/prp2.70091}
}
EUVIMED